Hebei Lansheng Biotech Co., Ltd.
Beijing Multigrass Formulation Co., Ltd.

Monsanto issues statement on glyphosate litigationqrcode

Aug. 15, 2018

Favorites Print
Forward
Aug. 15, 2018

In a Statement, Monsanto’s Vice President Scott Partridge said, “We are sympathetic to Mr. Johnson and his family. Today’s decision does not change the fact that more than 800 scientific studies and reviews – and conclusions by the U.S. Environmental Protection Agency, the U.S. National Institutes of Health and regulatory authorities around the world – support the fact that glyphosate does not cause cancer, and did not cause Mr. Johnson’s cancer. We will appeal this decision and continue to vigorously defend this product, which has a 40-year history of safe use and continues to be a vital, effective, and safe tool for farmers and others.”

On August 14, Monsanto ordered to pay $289m damages in a glyphosate cancer trial. Dewayne Johnson, a 46-year-old former groundskeeper, won victory in the landmark case on last Friday, with the jury determining that Monsanto’s Roundup caused his cancer and that the corporation failed to warn him of the health hazards from exposure. 

Picture 0/1200

More from AgroNews

Magazine

2020 Latin America Focus 2020 Biologicals Special
2020 Formulation & Adjuvant Technology Annual Review 2019
Chinese issue of Annual Review 2019 2019 CRO & CRAO Manual
Subscribe Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

Picture 0/1200

Subscribe to daily email alerts of AgroNews.